Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Clinical trial NCT01605331 · COMPLETED

Trial details

NCT number: NCT01605331
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2009-12-01
Primary completion: 2010-09-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.